Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

NCT00553462 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: erlotinib hydrochloride
DRUG: paclitaxel albumin-stabilized nanoparticle formulation
RADIATION: radiation therapy

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]